NLS Drug Development Pharma

The company’s manufacturing facility in Uppsala, Sweden, has been approved for manufacture of cytostatics by the Swedish Medical Products Agency. The approval concerns manufacture for sales in the EU. With this approval, the Medical Products Agency has confirmed that Oasmia’s manufacture of cytostatics meets the requirements of current Good Manufacturing Practice (cGMP) and Oasmia now has a […]

The company has registered a patent application for new substances for cancer treatment that selectively inhibit the enzyme HDAC6. The new patent application is based on HDAC6 inhibitors ability to affect mechanisms both inside of and outside of the cell nucleus. According to an announcement from the company it has been proven that HDAC6 has […]

SARomics Biostructures has entered into a strategic drug discovery partnership with inSili.com. The two companies are to perform collaborative research with the goal of finding novel bioactive agents against therapeutic drug targets. The focus of the collaboration aims at identifying new lead- and drug-like molecular entities with innovative modes of action, and obtaining structures of […]

The European Medicines Agency has introduced new fee incentives to support micro, small and medium-sized enterprises (SMEs) developing medicines for human and veterinary use.

The company will invest SEK 11.5 million for the establishment of a commercial cord blood bank in Sweden for private family saving of umbilical cord blood and other sources of stem cells.

Sobi’s partner Biogen Idec have announced that the US Food and Drug Administration (FDA) has approved Alprolix.